SlideShare a Scribd company logo
DIABETES
MELLITUS
By:
Thet-ul-Wafa Maqsood
Baqai Institute Of Pharmaceutical
Sciences,
Baqai Medical University,
Karachi, Pakistan.
OBJECTIVES:
• Introduction
• Types
• Pathogenesis
• Diagnosis
• Complications
• Treatment
• Counseling
INTRODUCTION:
Greek word Latin word
DIABETES MELLITUS
Siphon Sweet
Increased
output of
urine
Honey like
sweetness
Diabetes mellitus Is a
group of metabolic
diseases characterized
by increased levels of
glucose in the blood
(hyperglycemia)
resulting from defects
in insulin secretion,
insulin action, or both
HISTORY
Paul Langerhans
(Islets of langerhans of
pancreas)
Fredrick Bunting &
Charles Hebert
Nobel price 1923
Indian physician
Sushruta
Identify diabetes
Type 1 & Type 2
Indian physician
Term
“Madhumeha”
Honey urine
TARGET BLOOD GLUCOSE
LEVEL OF DIABETIC PATIENT
Types
Pre Prandial
Before meals
Post prandial
2 hours after meals
Non diabetic
4.0 to 5.9 mmol/L 7.8 mmol/L
Type 2 Diabetes 4 to 7 mmol/L 8.5 mmol/L
Type 1 Diabetes 4 to 7 mmol/L 9 mmol/L
Children with Type 1
Diabetes
4 to 8 mmol/L 10 mmol/L
NORMAL BLOOD SUGAR
RANGES
For the majority of healthy individuals, normal blood sugar
levels are as follows:
• Normal blood glucose level
• 4 mmol/L or 72 mg/ dl
• When operating normally
• 4.4 to 6.1 mmol/L (82 to 110 mg/dL)
• Shortly after a meal 7.8 mmol/L or 140 mg/dL
NORMAL METABOLISM
CONDITIONS OF DIABETES
There two conditions of diabetes are.
• Hyperglycemia
• Hypoglycemia
HYPERGLYCEMIA
When controlling your diabetes , but your blood glucose can
become too high .
This condition should be take seriously.
SYMPTOMS OF
HYPERGLYCEMIA
HYPOGLYCEMIA
Hypoglycemia occur when too little glucose is
present your blood.
• If not treated, low blood sugar lead to fainting
or seizure.
• A low blood sugar happen quickly & be life
threatening.
REASON :
• Improper diet
• Excessive amount of insulin injected.
EPIDEMEOLOGY
• The prevalence of diabetes is increasing rapidly
worldwide.
• The World Health Organization (2003) has predicted that by 2030
the number of adults with diabetes would have almost doubled
worldwide, from 177 million in 2000 to 370 million.
• The estimated worldwide prevalence of diabetes among
adults in 2010 was 285 million (6.4%) and this value is
predicted to rise to around 439 million (7.7%) by 2030
(Shaw et al., 2010).
INCIDENCE OF DIABETES
Estimated 245 million people globally
20% of adult population.
5% of all death each year.
80% of people with diabetes live in low & middle income
countries
The global incidence of DM is rising & the number of
effected is projected to exceed 300 million by year 2025
TYPES OF DIABETES
Types
Hyperglycemia
Diabetes
Mellitus
Type I
Type II
Diabetes
Insipidus
Gestational
Diabetes
TYPES
• Type 1 diabetes
• In Type 1 diabetes, the pancreas
(a large gland behind the
stomach) fails to produce insulin.
TYPES I (CONT.)
Symptoms
Type I Diabeties
DM TYPES I (CONT.)
Cause
• The exact cause is not
known.
• Can be autoimmuned.
• Or may possibly triggered
by a virus. This destroys
the part of the pancreas
which produces insulin.
TYPE 2 DIABETES
• In Type 2 diabetes, the body cells are
unable to use insulin properly (insulin
resistance).
DM TYPE 2 (CONT).
Causes
DM TYPE 2 (CONT).
•Symptoms
GESTATIONAL DIABETES
What is Gestational
diabetes?
• Gestational Diabetes is a form
of diabetes that occurs during
pregnancy and usually goes
away after the baby is born.
GESTATIONAL DIABETES
(CONT.)
GESTATIONAL DIABETES
(CONT.)
Who is at risk of developing gestational diabetes?
GESTATIONAL DIABETES
(CONT.)
Commonly asked Questions about Gestational
diabetes:
• How will Gestational
Diabetes affect the
baby?
• Will the baby be born
with diabetes?
• What happens after the
baby is born?
DIABETES INSIPIDUS
• Diabetes insipidus (DI)
Is a condition characterized
by excessive thirst and
excretion of large amounts of
severely diluted urine,
• No concern with elevated
blood glucose levels.
DIABETES INSIPIDUS
(CONT).Types Of Diabetes Insipidus:
Central Diabetes Insipidus
(CDI)
•Due to deficiency of antidiuretic hormone (ADH).
Nephrogenic Diabetes
Insipidus (NDI),
•which is due to kidney or nephron dysfunction
DIABETES INSIPIDUS
(CONT).
Signs and symptoms
DIABETES INSIPIDUS
(CONT.).
• Presentation:
It may present with
• fever,
• vomiting,
• diarrhea.
DIABETES INSIPIDUS
(CONT).
•Causes:
• Serious Head injury.
• Pituitary Tumor.
• Deficiency of Anti diuretic hormone (ADH).
• kidney or nephron dysfunction
RISK FACTORS:
Related to Diabetes Mellitus (DM)
RISK FACTORS:
.
RISK FACTORS (CONT.)
PATHOPHYSIOLOGY
OF DIABETES
PATHOPHYSIOLOGY OF
DIABETES
As blood glucose rises, the
body sends a signal to
the pancreas, which
releases insulin.
NORMAL PHYSIOLOGY
• Insulin is released by beta cells (β
cells) in to the blood
• Beta cells (β cells) are found in
the islets cells of pancreas
• Beta cells response to high level
of blood glucose and secrete
insulin
• Insulin absorb the glucose from
the blood for:-
• use as fuel
• conversion to other needed
molecules
• storage
FUNCTIONS OF INSULIN:-
• Balance glucose level
• Inhibit breakdown of glycogen
• Inhibit the process of gluconeogenesis
• Stimulate transport of glucose in to fat and muscle cells
• Stimulate the storage of glucose in glycogen form
• Stimulate the protein synthesis
CARBOHYDRATE
METABOLISM
• Carbohydrates are metabolized in the body
to glucose.
• CNS uses glucose as its primary energy
source. This is independent of insulin.
• Glucose is taken by the muscle to produce
energy (insulin required).
• Glucose is stored in the liver as glycogen
and in adipose tissues as fat.
• Insulin is produced and stored by the β-
cells of the pancreas 49
PATHOPHYSIOLOGY OF DIABETES
When you eat, your body
breaks food down into glucose.
Glucose is a
type of sugar that is
your body’s
main source
of energy.
a
type of sugar that is
your body’s
main source
of energy.
PATHOPHYSIOLOGY OF
DIABETES MELLITUS TYPE 1
It is a slowly T cell mediated
autoimmune diseases
in which β cells are destroyed
Symptoms occur when 70-90% cells are
destroyed
Due to destruction of beta cells insulin is
unable to release or poorly released
Resulting hyperglycemia
HOW Β CELLS ARE
DESTROYED:-
 beta cells are destroyed due
to
 Beta cell antibodies
production like GAD enzyme
antibodies
 Insulitis in which infiltration of
islets with mononuclear cells
PATHOPHSIOLOGY OF
DIABETES MELLITUS TYPE 1
The high blood glucose level
causes kidneys to excrete
glucose in the urine
(glycosuria)
Due to which the osmotic
pressure of the urine increases
Resulting inhibition of water
reabsorption by the kidneys
The net effect will be increased
urine production (polyuria)
and fliud loss
Lost blood volume will be
replaced from water held in
body cells and other body
compartments causing
dehydration and increased
thirst (polydipsia)
TYPE 2 DIABETES MELLITUS
PATHOPHYSIOLOGY
• Insulin resistance
• Body tissues do not respond to insulin
• Results in hyperglycemia
• Decreased (but not absent) production
of insulin
• Due to which blood glucose level
increases
TYPE 2
PATHOPHYSIOLOGY
• Resistance of insulin is due to
• Reduction of insulin cells
• Life style :- overeating especially obesity
may lead to resistance of insulin
DIAGNOSIS AND
COMPLICATIONS
OF DIABETES
DIAGNOSIS AND TEST:
• Symptoms of type
1 diabetes often
appear suddenly
and are often the
reason for
checking blood
sugar levels. The
American Diabetes
Association (ADA)
has recommended
screening
guidelines. The
ADA recommends
that the following
people be
screened for
diabetes
ANYONE WITH A BODY
MASS INDEX HIGHER THAN
25, REGARDLESS OF AGE,
• who has additional
risk factors, such as
high blood pressure,
a sedentary lifestyle,
a history of
polycystic ovary
syndrome, having
delivered a baby
who weighed more
than 9 pounds, a
history of diabetes in
pregnancy, high
cholesterol levels, a
history of heart
disease, and having
a close relative with
diabetes.
ANYONE OLDER THAN
AGE 45
• is advised to receive
an initial blood
sugar screening,
and then, if the
results are normal,
to be screened
every three years
thereafter.
TESTS FOR TYPE 1 AND TYPE 2
DIABETES AND PREDIABETES
• Glycated hemoglobin (A1C) test:
• This blood test indicates your average blood sugar
level for the past two to three months. It measures
the percentage of blood sugar attached to
hemoglobin, the oxygen-carrying protein in red
blood cells. The higher your blood sugar levels, the
more hemoglobin you'll have with sugar attached.
An A1C level of 6.5 percent or higher on two
separate tests indicates that you have diabetes. An
A1C between 5.7 and 6.4 percent indicates
prediabetes. Below 5.7 is considered normal.
• If the A1C test results aren't consistent, the test isn't
available, or if you have certain conditions that can
make the A1C test inaccurate — so— your doctor
may use the following tests to diagnose diabetes:
TESTS FOR TYPE 1 AND TYPE 2
DIABETES AND PREDIABETES
• Random blood sugar
• : A blood sample will be
taken at a random time.
Regardless of when you
last ate, a random blood
sugar level of 200
milligrams per deciliter
(mg/dL) — 11.1 millimoles
per liter (mmol/L) — or
higher suggests diabetes.
TESTS FOR TYPE 1 AND TYPE 2
DIABETES AND PREDIABETES
• Fasting blood sugar test:
• A blood sample will be
taken after an overnight
fast. A fasting blood sugar
level less than 100 mg/dL
(5.6 mmol/L) is normal. A
fasting blood sugar level
from 100 to 125 mg/dL (5.6
to 6.9 mmol/L) is
considered prediabetes. If
it's 126 mg/dL (7 mmol/L) or
higher on two separate
tests, you have diabetes.
TESTS FOR TYPE 1 AND TYPE 2
DIABETES AND PREDIABETES
• Oral glucose tolerance test:
• For this test, you fast overnight,
and the fasting blood sugar
level is measured. Then you
drink a sugary liquid, and blood
sugar levels are tested
periodically for the next two
hours. A blood sugar level less
than 140 mg/dL (7.8 mmol/L) is
normal. A reading of more than
200 mg/dL (11.1 mmol/L) after
two hours indicates diabetes. A
reading between 140 and 199
mg/dL (7.8 mmol/L and 11.0
mmol/L) indicates prediabetes.
If type 1 diabetes is suspected, your urine will be tested to look for the presence of
a byproduct produced when muscle and fat tissue are used for energy when the
body doesn't have enough insulin to use the available glucose (ketones).
COMPLICATIONS OF DIABETES
COMPLICATIONS:
• Possible complications include:
• Cardiovascular disease.
• Diabetes dramatically increases
the risk of various cardiovascular
problems, including coronary
artery disease with chest pain
(angina), heart attack, stroke
and narrowing of arteries
(atherosclerosis). If you have
diabetes, you are more likely to
have heart disease or stroke.
COMPLICATIONS:
Nerve damage (neuropathy). Excess sugar
can injure the walls of the tiny blood vessels (capillaries)
that nourish your nerves, especially in your legs. This can
cause tingling, numbness, burning or pain that usually
begins at the tips of the toes or fingers and gradually
spreads upward. Left untreated, you could lose all sense
of feeling in the affected limbs. Damage to the nerves
related to digestion can cause problems with nausea,
vomiting, diarrhea or constipation. For men, it may lead
to erectile dysfunction.
COMPLICATIONS:
 Kidney damage (nephropathy). The kidneys contain
millions of tiny blood vessel clusters (glomeruli) that filter
waste from your blood. Diabetes can damage this delicate
filtering system. Severe damage can lead to kidney failure
or irreversible end-stage kidney disease, which may require
dialysis or a kidney transplant.
 Eye damage (retinopathy). Diabetes can damage the
blood vessels of the retina (diabetic retinopathy), potentially
leading to blindness. Diabetes also increases the risk of
other serious vision conditions, such as cataracts and
glaucoma.
COMPLICATIONS:
 Foot damage. Nerve damage in the feet or poor blood flow
to the feet increases the risk of various foot complications.
Left untreated, cuts and blisters can develop serious
infections, which often heal poorly. These infections may
ultimately require toe, foot or leg amputation.
 Skin conditions. Diabetes may leave you more susceptible
to skin problems, including bacterial and fungal infections.
How Does Insulin Work?
1.In a healthy person, insulin helps turn
food into energy -- in an efficient
manner.
2. The stomach breaks down
carbohydrates from food into sugars,
including glucose. Glucose then enters
the bloodstream, which stimulates the
pancreas to release insulin in just the
right amount.
3. Insulin, a hormone, allows glucose to
enter cells throughout the body, where
it is used as fuel. Excess glucose is
stored in the liver.
1.Successful treatment makes all the difference
to long-term health, and achieving balanced
diabetes treatment can be the key to living with
both type 1 and type 2 diabetes.
2.Treatment varies for each individual, not
simply on the type of diabetes that they have,
but also more individual-specific diabetic
treatment differences.
INSULIN
1.Inside the pancreas, beta cells make the hormone insulin. With each meal,
beta cells release insulin to help the body use or store the glucose it gets
from food.
2.Insulin is prescribed to people with type 1 diabetes. This is because type 1
diabetes destroys beta cells in the pancreas, meaning that the body can no
longer produce insulin.
2.People with type 2 diabetes make insulin, but their bodies don’t respond
well to it. Some people with type 2 diabetes may take pills or insulin shots to
help their bodies use glucose for energy.
INSULIN ADMINISTRATION
Diabetes Medication
-Most diabetes drugs are designed for people
with type 2 diabetes who are unable to control
their blood sugar levels through strict diet and
exercise alone.
- But some, such as metformin, are sometimes
taken alongside insulin treatment for people
with type 1 diabetes.
Alpha-glucosidase inhibitors
-Alpha-glucosidase inhibitors are oral anti-
diabetic drugs used for diabetes mellitus type
2 that work by preventing the digestion of
carbohydrates (such as starch and table
sugar).
- Carbohydrates are normally converted into
simple sugars (monosaccharides), which can
be absorbed through the intestine.
- Hence, alpha-glucosidase inhibitors reduce
the impact of carbohydrates on blood sugar.
Mechanism of action
-Alpha-glucosidase inhibitors
are saccharides that act as competitive
inhibitors of enzymes needed to
digest carbohydrates, specifically alpha-
glucosidase enzymes in the brush border of
the small intestines.
-The membrane-bound intestinal alpha-
glucosidases hydrolyze oligosaccharides, trisa
ccharides, and disaccharides to glucose and
other monosaccharides in the small intestine.
Examples of alpha glucosidase inhibitors
- Acarbose (Precose):
Initial dose: 25 mg orally 3 times a day.
Maintenance dose: 50 to 100 mg orally 3
times a day.
- Miglitol (Glyset):
Initial dose: 25 mg orally 3 times a day at the
beginning (with the first bite) of each meal.
-Voglibose:
The recommended dose is 200-300 mcg 3
times/day.
Amylin analogs
- Amylin is a 37-amino acid peptide that is
stored in pancreatic beta cells and is co-
secreted with insulin.
-Amylin and insulin levels rise and fall in a
synchronous manner . Amylin and insulin have
complementary actions in regulating nutrient
levels in the circulation.
- Amylin is deficient in type 1 diabetes and
relatively deficient in insulin-requiring type 2
diabetes
-Amylin affects glucose control through several
mechanisms, including slowed gastric emptying,
regulation of postprandial glucagon, and reduction of
food intake.
- Glucagon-like peptide 1 (GLP-1) exhibits similar
properties as amylin, with the exception of insulin
secretory effects. Amylin, unlike GLP-1, does not
have insulin secretory effects, but both regulate
hyperglycemia in part through amelioration of
inappropriate glucagon secretion and gastric emptying
There is only one known example of amylin analog that is
pramlintide acetate that is an injectable effective in both type
1 and type 2 diabetes.
Biguanidine drugs
Mechanistic aspects:
-Biguanides do not affect the output of insulin, unlike
other hypoglycemic agents such as sulfonylureas and meglitinides.
-Therefore, not only are they effective in Type 2 diabetics but
they can also be effective in Type 1 patients in concert with
insulin therapy.
- The mechanism of action of biguanides is not fully understood.
Mainly used in Type II Diabetes, Metformin is considered to
increase insulin sensitivity in vivo, resulting in reduced plasma
glucose concentrations, increased glucose uptake, and decreased
gluconeogenesis.
Examples Of biguanides:
Metformin:
-widely used in treatment of diabetes mellitus
type 2
- 500 mg orally twice a day (with the morning
and evening meal)
Phenformin:
- withdrawn from the market in most
countries due to toxic effects.
Buformin:
- withdrawn from the market due to toxic
effects
SULFONYLUREAS
- Sulfonylurea (UK: sulphonylurea)
derivatives are a class of antidiabetic drugs.
-They are used in the management
of diabetes mellitus type 2. They act by
increasing insulin release from the beta
cells in the pancreas.
- There are two generations of sulfonylureas,
both being oral hypoglycemic agents used in
type diabetes mellitus.
Mechanism of action:
-Sulfonylureas bind to an ATP-dependent K+(KATP) channel
on the cell membrane of pancreatic beta cells.
-This inhibits a tonic, hyperpolarizing efflux of potassium,
thus causing the electric potential over the membrane to
become more positive.
-This depolarizationopens voltage-gated Ca2+ channels.
The rise in intracellular calcium leads to increased fusion
of insulin granulae with the cell membrane, and therefore
increased secretion of (pro)insulin.
Drugs in this class
First generation:
- Carbutamide
- Acetohexamide
-Chlorpropamide
- Tolbutamide
Second generation:
- Gliclazide
- Glibenclamide (glyburide)
- Glibornuride
- Glimepiride
THIAZOLIDINEDIONE
- Thiazolidinediones , also known
as glitazones, are a class of medications used
in the treatment of diabetes mellitus type 2
Mechanism of action:
- Thiazolidinediones or TZDs act by
activating PPARs (peroxisome proliferator-
activated receptors), a group of nuclear
receptors, with greatest specificity
for PPARγ (gamma). The
endogenous ligands for these receptors are
free fatty acids (FFAs) and eicosanoids
- When activated, the receptor binds
to DNA in complex with the retinoid X
receptor (RXR), another nuclear receptor,
increasing transcription of a number of
specific genes and decreasing transcription of
others.
- Although there are still many unknowns
about the mechanism of action of TZDs in
type 2 diabetes, it is clear that these agents
have the potential to benefit the full 'insulin
resistance syndrome' associated with the
disease. Therefore, TZDs may also have
potential benefits on the secondary
complications of type 2 diabetes, such as
cardiovascular disease.
Members of the class
Rosiglitazone (Avandia)
Pioglitazone (Actos)
Troglitazone (Rezulin)
Initial dose: 4 mg/day orally as a single daily
dose or in two divided doses. Doses may be
taken without regard to meals.
Maintenance dose: The dose may be
increased to 8 mg daily in patients who fail to
respond adequately following 12 weeks of
initial therapy.
Initial dose: 15 mg to 30 mg orally once a day.
Doses may be taken without regard to meals.
Maintenance dose: In patients who respond
inadequately to the initial dose, it may be
increased in increments up to 45 mg once
daily.
ADVERSE EFFECTS OF
DRUGS:
COUNSELING
Of a diabetic patient
WHY TO COUNSEL?
Diabetes
Mellitus
Chronic
Disease
Complications
Counseling
Improve
quality of life
THE SIX MOST
ASKED
QUESTIONS
ABOUT DIABETES
Q. WHAT IS
DIABETES?
Diabetes is a disease.
Q. CAN YOU
‘CATCH’ DIABETES?
No,
Q. AT WHAT AGE DO
YOU GET DIABETES?
A. Anyone can get diabetes at any age.
Q. WHAT TYPES OF
PEOPLE GET
DIABETES?
A. Anyone may develop diabetes.
Q. HOW CAN I TELL
IF I HAVE DIABETES?
A. By the symptoms.
Q. CAN DIABETES
BE CURED?
A. As yet there is no cure. However, excellent treatment is
available.
COUNSELING REGARDING
LIFESTYLE MODIFICATION
(NON-PHARMACOLOGICAL
THERAPY)
Exerc
ise
Smokin
g
Diet
DIABETES AND DIET
CHOOSE HIGH-FIBER, SLOW-
RELEASE CARBOHYDRATES
Instead of… Try these high-fiber options…
White rice Brown rice or wild rice
White potatoes (including fries and mashed
potatoes)
Sweet potatoes, yams, winter squash,
cauliflower mash
Regular pasta Whole-wheat pasta
White bread Whole-wheat or whole-grain bread
Corn Peas or leafy greens
DIABETES AND DIET
(CONT).
Be smart about sweets
DIABETES AND DIET
(CONT.).
Proceed with caution when it comes
to alcohol
DIABETES AND DIET (CONT.).
CHOOSE FATS WISELY
• Ways to reduce unhealthy fats and add healthy fats:
Instead of… Try these options…
vegetable oil or butter Cook with olive oil
chips or crackers, try snacking on nuts or seeds.
frying grill, broil, bake, or stir-fry.
Red meat. Serve fish 2 or 3 times week
cheese Add avocado to your
sandwiches
shortening or butter When baking, use canola oil
NUTRITIVE CHART
•Fruits:-
• 1 serving contain:-
protein 1 gm
carbohydrate 15 gm
Sodium 5 mg
Potassium 150 mg
Kcal 60
FRUIT ITEMS
Serving size:-
Grape fruit ½ medium
Grapes 22
Mango ½ medium
peach 1 small
pineapple ½ medium
Apple 1 medium
VEGETABLES
• 1 Serving contains:-
Protein 2 gm
Carbohydrate 5 gm
Sodium 10 mg
Potassium 200 mg
Kcal 25
VEGETABLES
Food items Serving size.
Cabbage ½ Cup
Carrot ½ Cup
Cauliflower ½ Cup
Cucumber 1 Cup
Onions ½ Cup
Peas 1/4 Cup
Potatoes ½ Cup
MEAT
1 serving contain:-
protein 8 gm
Fat 3 gm
Sodium 25 mg
potassium 100 mg
Kcal 55-75
MEAT
Food items Serving Size
Beef 1 Oz
Chicken 1 Oz
Fish 1 Oz
Large Egg 1
FOODS TO AVOID
• BANANA
• DATES
• WATER MELON
• ORANGE
• POMGRANATE
• PAPAYA
• Red meat
COUNSELING REGARDING
LIFESTYLE MODIFICATION
(NON-PHARMACOLOGICAL
THERAPY)
• Diabetes and Exercise:
Type II
(desired level is 3-4 times a week)
Type I
(Care must be taken to have adequate metabolic control)
Exercise is not recommended if patient has poorly controlled
blood glucose level
COUNSELING REGARDING
LIFESTYLE MODIFICATION
(NON-PHARMACOLOGICAL
THERAPY)
 Diabetes and Smoking
THANK YOU
QUESTIONS?

More Related Content

What's hot

Diabetes mellitus ppt
Diabetes mellitus pptDiabetes mellitus ppt
Diabetes mellitus ppt
RaginiKanojiaB1
 
Diabetes Powerpoint 6
Diabetes  Powerpoint 6Diabetes  Powerpoint 6
Diabetes Powerpoint 6
Chocolate42
 
Diabetes type 2
Diabetes type 2Diabetes type 2
Diabetes type 2
Fatima Gul
 
Diabetes mellitus presentation
Diabetes mellitus presentationDiabetes mellitus presentation
Diabetes mellitus presentation
lakshmi das
 
Diabetes mellitus
Diabetes mellitusDiabetes mellitus
Diabetes mellitus
Abhra Ghosh
 
Diabetes
DiabetesDiabetes
Diabetes
allykatty
 
Diabetes mellitus an overview
Diabetes mellitus an overviewDiabetes mellitus an overview
Diabetes mellitus an overviewRuth Nwokoma
 
Diabetes
DiabetesDiabetes
Diabetes
Poonam Singh
 
...DIAGNOSIS OF DIABETES MELLITUS...
...DIAGNOSIS OF DIABETES MELLITUS......DIAGNOSIS OF DIABETES MELLITUS...
...DIAGNOSIS OF DIABETES MELLITUS...
Dr.Subir Kumar
 
Diabetes
DiabetesDiabetes
Diabetes
Raymond Arhin
 
Prediabetes Awadhesh Med
Prediabetes Awadhesh MedPrediabetes Awadhesh Med
Diabetes mellitus
Diabetes mellitusDiabetes mellitus
Diabetes mellitus
Lih Yin Chong
 
Pathophysiology of diabetes mellitus
Pathophysiology of diabetes mellitusPathophysiology of diabetes mellitus
Pathophysiology of diabetes mellitus
niva niva
 
Type 2 dm
Type 2 dmType 2 dm
Type 2 dm
Drmukesh Samota
 
Diabetes Mellitus (DM)
Diabetes Mellitus (DM)Diabetes Mellitus (DM)
Diabetes Mellitus (DM)
Abhay Rajpoot
 
Diagnosis of diabetes mellitus
Diagnosis of diabetes mellitus  Diagnosis of diabetes mellitus
Diagnosis of diabetes mellitus Dilek Gogas Yavuz
 
Complications+of+Diabetes
Complications+of+DiabetesComplications+of+Diabetes
Complications+of+Diabetesdhavalshah4424
 
Diabetes mellitus
Diabetes mellitusDiabetes mellitus
Diabetes mellitus
Subramani Parasuraman
 
Diabetes
DiabetesDiabetes
Diabetes
Fatima AlSaadi
 

What's hot (20)

Diabetes mellitus ppt
Diabetes mellitus pptDiabetes mellitus ppt
Diabetes mellitus ppt
 
Diabetes Powerpoint 6
Diabetes  Powerpoint 6Diabetes  Powerpoint 6
Diabetes Powerpoint 6
 
Diabetes type 2
Diabetes type 2Diabetes type 2
Diabetes type 2
 
Diabetes
DiabetesDiabetes
Diabetes
 
Diabetes mellitus presentation
Diabetes mellitus presentationDiabetes mellitus presentation
Diabetes mellitus presentation
 
Diabetes mellitus
Diabetes mellitusDiabetes mellitus
Diabetes mellitus
 
Diabetes
DiabetesDiabetes
Diabetes
 
Diabetes mellitus an overview
Diabetes mellitus an overviewDiabetes mellitus an overview
Diabetes mellitus an overview
 
Diabetes
DiabetesDiabetes
Diabetes
 
...DIAGNOSIS OF DIABETES MELLITUS...
...DIAGNOSIS OF DIABETES MELLITUS......DIAGNOSIS OF DIABETES MELLITUS...
...DIAGNOSIS OF DIABETES MELLITUS...
 
Diabetes
DiabetesDiabetes
Diabetes
 
Prediabetes Awadhesh Med
Prediabetes Awadhesh MedPrediabetes Awadhesh Med
Prediabetes Awadhesh Med
 
Diabetes mellitus
Diabetes mellitusDiabetes mellitus
Diabetes mellitus
 
Pathophysiology of diabetes mellitus
Pathophysiology of diabetes mellitusPathophysiology of diabetes mellitus
Pathophysiology of diabetes mellitus
 
Type 2 dm
Type 2 dmType 2 dm
Type 2 dm
 
Diabetes Mellitus (DM)
Diabetes Mellitus (DM)Diabetes Mellitus (DM)
Diabetes Mellitus (DM)
 
Diagnosis of diabetes mellitus
Diagnosis of diabetes mellitus  Diagnosis of diabetes mellitus
Diagnosis of diabetes mellitus
 
Complications+of+Diabetes
Complications+of+DiabetesComplications+of+Diabetes
Complications+of+Diabetes
 
Diabetes mellitus
Diabetes mellitusDiabetes mellitus
Diabetes mellitus
 
Diabetes
DiabetesDiabetes
Diabetes
 

Viewers also liked

Diabetic neuropathy and retinopathy
Diabetic neuropathy and retinopathyDiabetic neuropathy and retinopathy
Diabetic neuropathy and retinopathyraj kumar
 
Insulin
InsulinInsulin
Insulin
Shanmukh Vss
 
Long term complications due to the diabetes
Long term complications due to the diabetesLong term complications due to the diabetes
Long term complications due to the diabetes
shivdixit4
 
DIABETES MELLITUS and surgeon
DIABETES MELLITUS and surgeonDIABETES MELLITUS and surgeon
DIABETES MELLITUS and surgeon
Vikas Kumar
 
Metabolic syndrome november 2014
Metabolic syndrome november 2014Metabolic syndrome november 2014
Metabolic syndrome november 2014
Mohamed BADR
 
Macrovascular disease in diabetes
Macrovascular disease in diabetesMacrovascular disease in diabetes
Macrovascular disease in diabetesPeninsulaEndocrine
 
Multi nodular goitre (MNG)
Multi nodular goitre (MNG)Multi nodular goitre (MNG)
Multi nodular goitre (MNG)
Laya Pillai
 
Complication of diabetes cpg DM 2015
Complication of diabetes cpg DM 2015Complication of diabetes cpg DM 2015
Complication of diabetes cpg DM 2015
siti hamidah
 
Complications of DM
Complications of DMComplications of DM
Complications of DM
snich
 
Complications of diabetes melitue
Complications of diabetes melitueComplications of diabetes melitue
Complications of diabetes melitue
Izwan Samsi
 
Obesity Epidemic (Research Paper)
Obesity Epidemic (Research Paper) Obesity Epidemic (Research Paper)
Obesity Epidemic (Research Paper)
Elizabeth Shubsda, MBA
 
Chronic complication of diabetes melitus
Chronic complication of diabetes melitusChronic complication of diabetes melitus
Chronic complication of diabetes melitus
Nur Idris
 
Chronic complications of diabetes mellitus
Chronic complications of diabetes mellitusChronic complications of diabetes mellitus
Chronic complications of diabetes mellitusHamza AlGhamdi
 
Acute & chro. complications of d. m.
Acute & chro. complications of d. m.Acute & chro. complications of d. m.
Acute & chro. complications of d. m.
Rahul Garg
 
Complications Of Diabetes
Complications Of DiabetesComplications Of Diabetes
Complications Of Diabetes
Ritika Sahay
 
COMPLICATIONS OF DIABETES BY DR BASHIR AHMED DAR ASSOCIATE PROFESSOR MEDICINE...
COMPLICATIONS OF DIABETES BY DR BASHIR AHMED DAR ASSOCIATE PROFESSOR MEDICINE...COMPLICATIONS OF DIABETES BY DR BASHIR AHMED DAR ASSOCIATE PROFESSOR MEDICINE...
COMPLICATIONS OF DIABETES BY DR BASHIR AHMED DAR ASSOCIATE PROFESSOR MEDICINE...
Prof Dr Bashir Ahmed Dar
 
Childhood diabetes mellitus and its complications
Childhood diabetes mellitus and its complicationsChildhood diabetes mellitus and its complications
Childhood diabetes mellitus and its complications
Dr. Saad Saleh Al Ani
 
Acute and chronic complications of DM
Acute and chronic  complications  of DMAcute and chronic  complications  of DM
Acute and chronic complications of DM
Dr. Kapil Dev Doddamani
 

Viewers also liked (20)

Diabetes mellitus
Diabetes mellitusDiabetes mellitus
Diabetes mellitus
 
Diabetic neuropathy and retinopathy
Diabetic neuropathy and retinopathyDiabetic neuropathy and retinopathy
Diabetic neuropathy and retinopathy
 
Diabetes mellitus
Diabetes mellitusDiabetes mellitus
Diabetes mellitus
 
Insulin
InsulinInsulin
Insulin
 
Long term complications due to the diabetes
Long term complications due to the diabetesLong term complications due to the diabetes
Long term complications due to the diabetes
 
DIABETES MELLITUS and surgeon
DIABETES MELLITUS and surgeonDIABETES MELLITUS and surgeon
DIABETES MELLITUS and surgeon
 
Metabolic syndrome november 2014
Metabolic syndrome november 2014Metabolic syndrome november 2014
Metabolic syndrome november 2014
 
Macrovascular disease in diabetes
Macrovascular disease in diabetesMacrovascular disease in diabetes
Macrovascular disease in diabetes
 
Multi nodular goitre (MNG)
Multi nodular goitre (MNG)Multi nodular goitre (MNG)
Multi nodular goitre (MNG)
 
Complication of diabetes cpg DM 2015
Complication of diabetes cpg DM 2015Complication of diabetes cpg DM 2015
Complication of diabetes cpg DM 2015
 
Complications of DM
Complications of DMComplications of DM
Complications of DM
 
Complications of diabetes melitue
Complications of diabetes melitueComplications of diabetes melitue
Complications of diabetes melitue
 
Obesity Epidemic (Research Paper)
Obesity Epidemic (Research Paper) Obesity Epidemic (Research Paper)
Obesity Epidemic (Research Paper)
 
Chronic complication of diabetes melitus
Chronic complication of diabetes melitusChronic complication of diabetes melitus
Chronic complication of diabetes melitus
 
Chronic complications of diabetes mellitus
Chronic complications of diabetes mellitusChronic complications of diabetes mellitus
Chronic complications of diabetes mellitus
 
Acute & chro. complications of d. m.
Acute & chro. complications of d. m.Acute & chro. complications of d. m.
Acute & chro. complications of d. m.
 
Complications Of Diabetes
Complications Of DiabetesComplications Of Diabetes
Complications Of Diabetes
 
COMPLICATIONS OF DIABETES BY DR BASHIR AHMED DAR ASSOCIATE PROFESSOR MEDICINE...
COMPLICATIONS OF DIABETES BY DR BASHIR AHMED DAR ASSOCIATE PROFESSOR MEDICINE...COMPLICATIONS OF DIABETES BY DR BASHIR AHMED DAR ASSOCIATE PROFESSOR MEDICINE...
COMPLICATIONS OF DIABETES BY DR BASHIR AHMED DAR ASSOCIATE PROFESSOR MEDICINE...
 
Childhood diabetes mellitus and its complications
Childhood diabetes mellitus and its complicationsChildhood diabetes mellitus and its complications
Childhood diabetes mellitus and its complications
 
Acute and chronic complications of DM
Acute and chronic  complications  of DMAcute and chronic  complications  of DM
Acute and chronic complications of DM
 

Similar to Diabetes Mellitus

Diabetes mellitus class
Diabetes mellitus classDiabetes mellitus class
Diabetes mellitus class
vdsriram
 
CASE STUDY ON DIABETES MELLITUS PATIENT.pptx
CASE STUDY ON DIABETES MELLITUS PATIENT.pptxCASE STUDY ON DIABETES MELLITUS PATIENT.pptx
CASE STUDY ON DIABETES MELLITUS PATIENT.pptx
MOHAMMED AYESH ABDO HASAN default
 
Diabetes Mellitus: Approach to Management
Diabetes Mellitus: Approach to ManagementDiabetes Mellitus: Approach to Management
Diabetes Mellitus: Approach to Management
Kemi Dele-Ijagbulu
 
BIOCHEMICAL PROFILE OF DIABETES MELLITUS by DR MUSTANSAR FJMC LAHORE
BIOCHEMICAL PROFILE OF DIABETES MELLITUS   by  DR MUSTANSAR  FJMC LAHORE BIOCHEMICAL PROFILE OF DIABETES MELLITUS   by  DR MUSTANSAR  FJMC LAHORE
BIOCHEMICAL PROFILE OF DIABETES MELLITUS by DR MUSTANSAR FJMC LAHORE
Dr Muhammad Mustansar
 
Diabetes mellitus
Diabetes mellitusDiabetes mellitus
Diabetes mellitus
Sara Ravi
 
Approach to Diabetes mellitus.ppt.pptx
Approach to Diabetes mellitus.ppt.pptxApproach to Diabetes mellitus.ppt.pptx
Approach to Diabetes mellitus.ppt.pptx
FebithaVP
 
Daibetes Mellitus .ppt
Daibetes Mellitus .pptDaibetes Mellitus .ppt
Daibetes Mellitus .ppt
AmanKarn5
 
15.Diabetes lecture.pptx
15.Diabetes  lecture.pptx15.Diabetes  lecture.pptx
15.Diabetes lecture.pptx
mulenga22
 
Management of a Patient with Diabetes.pptx
Management of a Patient with Diabetes.pptxManagement of a Patient with Diabetes.pptx
Management of a Patient with Diabetes.pptx
EmmanuelUsiku
 
Diabetes Mellites type 1 and type 2
Diabetes Mellites type 1 and type 2Diabetes Mellites type 1 and type 2
Diabetes Mellites type 1 and type 2
Nadia Shams
 
Sarah's DM.pptx
Sarah's DM.pptxSarah's DM.pptx
Sarah's DM.pptx
Rebecca56466
 
Diabetes mellitus
Diabetes mellitusDiabetes mellitus
Diabetes mellitus
Rikha Decha
 
DIABETES at a glance.pptx
DIABETES at a glance.pptxDIABETES at a glance.pptx
DIABETES at a glance.pptx
AKENUWAHILDA
 
Type 1 Diabetes and Insulin UG Classes.pptx
Type 1 Diabetes and Insulin UG Classes.pptxType 1 Diabetes and Insulin UG Classes.pptx
Type 1 Diabetes and Insulin UG Classes.pptx
GovindRankawat1
 
Diabetes Mellitus MBC 120.pptx
Diabetes Mellitus MBC 120.pptxDiabetes Mellitus MBC 120.pptx
Diabetes Mellitus MBC 120.pptx
chishimbalouis1
 
Diabetes Mellitus & Nurses Role
Diabetes Mellitus & Nurses RoleDiabetes Mellitus & Nurses Role
Diabetes Mellitus & Nurses Role
Prof Vijayraddi
 
Diabetes Mellitus.pptx
Diabetes Mellitus.pptxDiabetes Mellitus.pptx
Diabetes Mellitus.pptx
GhaffarAhmed9
 
Diabetes mellitus.pptx
Diabetes mellitus.pptxDiabetes mellitus.pptx
Diabetes mellitus.pptx
PoonumTyagi
 
Diabetes Mellitus (Endocrine disorder)
Diabetes Mellitus (Endocrine disorder) Diabetes Mellitus (Endocrine disorder)
Diabetes Mellitus (Endocrine disorder)
Rahul Ranjan
 
DIABETES MELLITUS ITS TYPES AND TREATMENT
DIABETES MELLITUS ITS TYPES AND TREATMENTDIABETES MELLITUS ITS TYPES AND TREATMENT
DIABETES MELLITUS ITS TYPES AND TREATMENT
aanmol
 

Similar to Diabetes Mellitus (20)

Diabetes mellitus class
Diabetes mellitus classDiabetes mellitus class
Diabetes mellitus class
 
CASE STUDY ON DIABETES MELLITUS PATIENT.pptx
CASE STUDY ON DIABETES MELLITUS PATIENT.pptxCASE STUDY ON DIABETES MELLITUS PATIENT.pptx
CASE STUDY ON DIABETES MELLITUS PATIENT.pptx
 
Diabetes Mellitus: Approach to Management
Diabetes Mellitus: Approach to ManagementDiabetes Mellitus: Approach to Management
Diabetes Mellitus: Approach to Management
 
BIOCHEMICAL PROFILE OF DIABETES MELLITUS by DR MUSTANSAR FJMC LAHORE
BIOCHEMICAL PROFILE OF DIABETES MELLITUS   by  DR MUSTANSAR  FJMC LAHORE BIOCHEMICAL PROFILE OF DIABETES MELLITUS   by  DR MUSTANSAR  FJMC LAHORE
BIOCHEMICAL PROFILE OF DIABETES MELLITUS by DR MUSTANSAR FJMC LAHORE
 
Diabetes mellitus
Diabetes mellitusDiabetes mellitus
Diabetes mellitus
 
Approach to Diabetes mellitus.ppt.pptx
Approach to Diabetes mellitus.ppt.pptxApproach to Diabetes mellitus.ppt.pptx
Approach to Diabetes mellitus.ppt.pptx
 
Daibetes Mellitus .ppt
Daibetes Mellitus .pptDaibetes Mellitus .ppt
Daibetes Mellitus .ppt
 
15.Diabetes lecture.pptx
15.Diabetes  lecture.pptx15.Diabetes  lecture.pptx
15.Diabetes lecture.pptx
 
Management of a Patient with Diabetes.pptx
Management of a Patient with Diabetes.pptxManagement of a Patient with Diabetes.pptx
Management of a Patient with Diabetes.pptx
 
Diabetes Mellites type 1 and type 2
Diabetes Mellites type 1 and type 2Diabetes Mellites type 1 and type 2
Diabetes Mellites type 1 and type 2
 
Sarah's DM.pptx
Sarah's DM.pptxSarah's DM.pptx
Sarah's DM.pptx
 
Diabetes mellitus
Diabetes mellitusDiabetes mellitus
Diabetes mellitus
 
DIABETES at a glance.pptx
DIABETES at a glance.pptxDIABETES at a glance.pptx
DIABETES at a glance.pptx
 
Type 1 Diabetes and Insulin UG Classes.pptx
Type 1 Diabetes and Insulin UG Classes.pptxType 1 Diabetes and Insulin UG Classes.pptx
Type 1 Diabetes and Insulin UG Classes.pptx
 
Diabetes Mellitus MBC 120.pptx
Diabetes Mellitus MBC 120.pptxDiabetes Mellitus MBC 120.pptx
Diabetes Mellitus MBC 120.pptx
 
Diabetes Mellitus & Nurses Role
Diabetes Mellitus & Nurses RoleDiabetes Mellitus & Nurses Role
Diabetes Mellitus & Nurses Role
 
Diabetes Mellitus.pptx
Diabetes Mellitus.pptxDiabetes Mellitus.pptx
Diabetes Mellitus.pptx
 
Diabetes mellitus.pptx
Diabetes mellitus.pptxDiabetes mellitus.pptx
Diabetes mellitus.pptx
 
Diabetes Mellitus (Endocrine disorder)
Diabetes Mellitus (Endocrine disorder) Diabetes Mellitus (Endocrine disorder)
Diabetes Mellitus (Endocrine disorder)
 
DIABETES MELLITUS ITS TYPES AND TREATMENT
DIABETES MELLITUS ITS TYPES AND TREATMENTDIABETES MELLITUS ITS TYPES AND TREATMENT
DIABETES MELLITUS ITS TYPES AND TREATMENT
 

Recently uploaded

Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfMANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
Jim Jacob Roy
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Dr KHALID B.M
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
Anujkumaranit
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
Anurag Sharma
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
MedicoseAcademics
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Savita Shen $i11
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
KafrELShiekh University
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
DR SETH JOTHAM
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
touseefaziz1
 
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyayaCharaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Dr KHALID B.M
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Savita Shen $i11
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
Catherine Liao
 

Recently uploaded (20)

Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfMANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
 
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyayaCharaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
 

Diabetes Mellitus

  • 1. DIABETES MELLITUS By: Thet-ul-Wafa Maqsood Baqai Institute Of Pharmaceutical Sciences, Baqai Medical University, Karachi, Pakistan.
  • 2. OBJECTIVES: • Introduction • Types • Pathogenesis • Diagnosis • Complications • Treatment • Counseling
  • 3.
  • 4.
  • 5. INTRODUCTION: Greek word Latin word DIABETES MELLITUS Siphon Sweet Increased output of urine Honey like sweetness
  • 6.
  • 7. Diabetes mellitus Is a group of metabolic diseases characterized by increased levels of glucose in the blood (hyperglycemia) resulting from defects in insulin secretion, insulin action, or both
  • 9. Paul Langerhans (Islets of langerhans of pancreas) Fredrick Bunting & Charles Hebert Nobel price 1923
  • 10. Indian physician Sushruta Identify diabetes Type 1 & Type 2 Indian physician Term “Madhumeha” Honey urine
  • 11. TARGET BLOOD GLUCOSE LEVEL OF DIABETIC PATIENT Types Pre Prandial Before meals Post prandial 2 hours after meals Non diabetic 4.0 to 5.9 mmol/L 7.8 mmol/L Type 2 Diabetes 4 to 7 mmol/L 8.5 mmol/L Type 1 Diabetes 4 to 7 mmol/L 9 mmol/L Children with Type 1 Diabetes 4 to 8 mmol/L 10 mmol/L
  • 12. NORMAL BLOOD SUGAR RANGES For the majority of healthy individuals, normal blood sugar levels are as follows: • Normal blood glucose level • 4 mmol/L or 72 mg/ dl • When operating normally • 4.4 to 6.1 mmol/L (82 to 110 mg/dL) • Shortly after a meal 7.8 mmol/L or 140 mg/dL
  • 14. CONDITIONS OF DIABETES There two conditions of diabetes are. • Hyperglycemia • Hypoglycemia
  • 15. HYPERGLYCEMIA When controlling your diabetes , but your blood glucose can become too high . This condition should be take seriously.
  • 17. HYPOGLYCEMIA Hypoglycemia occur when too little glucose is present your blood. • If not treated, low blood sugar lead to fainting or seizure. • A low blood sugar happen quickly & be life threatening. REASON : • Improper diet • Excessive amount of insulin injected.
  • 18.
  • 19.
  • 20. EPIDEMEOLOGY • The prevalence of diabetes is increasing rapidly worldwide. • The World Health Organization (2003) has predicted that by 2030 the number of adults with diabetes would have almost doubled worldwide, from 177 million in 2000 to 370 million. • The estimated worldwide prevalence of diabetes among adults in 2010 was 285 million (6.4%) and this value is predicted to rise to around 439 million (7.7%) by 2030 (Shaw et al., 2010).
  • 21.
  • 22. INCIDENCE OF DIABETES Estimated 245 million people globally 20% of adult population. 5% of all death each year.
  • 23. 80% of people with diabetes live in low & middle income countries The global incidence of DM is rising & the number of effected is projected to exceed 300 million by year 2025
  • 25. Types
  • 27. TYPES • Type 1 diabetes • In Type 1 diabetes, the pancreas (a large gland behind the stomach) fails to produce insulin.
  • 29. DM TYPES I (CONT.) Cause • The exact cause is not known. • Can be autoimmuned. • Or may possibly triggered by a virus. This destroys the part of the pancreas which produces insulin.
  • 30. TYPE 2 DIABETES • In Type 2 diabetes, the body cells are unable to use insulin properly (insulin resistance).
  • 31. DM TYPE 2 (CONT). Causes
  • 32. DM TYPE 2 (CONT). •Symptoms
  • 33. GESTATIONAL DIABETES What is Gestational diabetes? • Gestational Diabetes is a form of diabetes that occurs during pregnancy and usually goes away after the baby is born.
  • 35. GESTATIONAL DIABETES (CONT.) Who is at risk of developing gestational diabetes?
  • 36. GESTATIONAL DIABETES (CONT.) Commonly asked Questions about Gestational diabetes: • How will Gestational Diabetes affect the baby? • Will the baby be born with diabetes? • What happens after the baby is born?
  • 37. DIABETES INSIPIDUS • Diabetes insipidus (DI) Is a condition characterized by excessive thirst and excretion of large amounts of severely diluted urine, • No concern with elevated blood glucose levels.
  • 38. DIABETES INSIPIDUS (CONT).Types Of Diabetes Insipidus: Central Diabetes Insipidus (CDI) •Due to deficiency of antidiuretic hormone (ADH). Nephrogenic Diabetes Insipidus (NDI), •which is due to kidney or nephron dysfunction
  • 40. DIABETES INSIPIDUS (CONT.). • Presentation: It may present with • fever, • vomiting, • diarrhea.
  • 41. DIABETES INSIPIDUS (CONT). •Causes: • Serious Head injury. • Pituitary Tumor. • Deficiency of Anti diuretic hormone (ADH). • kidney or nephron dysfunction
  • 42. RISK FACTORS: Related to Diabetes Mellitus (DM)
  • 46. PATHOPHYSIOLOGY OF DIABETES As blood glucose rises, the body sends a signal to the pancreas, which releases insulin.
  • 47. NORMAL PHYSIOLOGY • Insulin is released by beta cells (β cells) in to the blood • Beta cells (β cells) are found in the islets cells of pancreas • Beta cells response to high level of blood glucose and secrete insulin • Insulin absorb the glucose from the blood for:- • use as fuel • conversion to other needed molecules • storage
  • 48. FUNCTIONS OF INSULIN:- • Balance glucose level • Inhibit breakdown of glycogen • Inhibit the process of gluconeogenesis • Stimulate transport of glucose in to fat and muscle cells • Stimulate the storage of glucose in glycogen form • Stimulate the protein synthesis
  • 49. CARBOHYDRATE METABOLISM • Carbohydrates are metabolized in the body to glucose. • CNS uses glucose as its primary energy source. This is independent of insulin. • Glucose is taken by the muscle to produce energy (insulin required). • Glucose is stored in the liver as glycogen and in adipose tissues as fat. • Insulin is produced and stored by the β- cells of the pancreas 49
  • 50. PATHOPHYSIOLOGY OF DIABETES When you eat, your body breaks food down into glucose. Glucose is a type of sugar that is your body’s main source of energy. a type of sugar that is your body’s main source of energy.
  • 51. PATHOPHYSIOLOGY OF DIABETES MELLITUS TYPE 1 It is a slowly T cell mediated autoimmune diseases in which β cells are destroyed Symptoms occur when 70-90% cells are destroyed Due to destruction of beta cells insulin is unable to release or poorly released Resulting hyperglycemia
  • 52. HOW Β CELLS ARE DESTROYED:-  beta cells are destroyed due to  Beta cell antibodies production like GAD enzyme antibodies  Insulitis in which infiltration of islets with mononuclear cells
  • 53. PATHOPHSIOLOGY OF DIABETES MELLITUS TYPE 1 The high blood glucose level causes kidneys to excrete glucose in the urine (glycosuria) Due to which the osmotic pressure of the urine increases Resulting inhibition of water reabsorption by the kidneys The net effect will be increased urine production (polyuria) and fliud loss Lost blood volume will be replaced from water held in body cells and other body compartments causing dehydration and increased thirst (polydipsia)
  • 54. TYPE 2 DIABETES MELLITUS PATHOPHYSIOLOGY • Insulin resistance • Body tissues do not respond to insulin • Results in hyperglycemia • Decreased (but not absent) production of insulin • Due to which blood glucose level increases
  • 55. TYPE 2 PATHOPHYSIOLOGY • Resistance of insulin is due to • Reduction of insulin cells • Life style :- overeating especially obesity may lead to resistance of insulin
  • 57. DIAGNOSIS AND TEST: • Symptoms of type 1 diabetes often appear suddenly and are often the reason for checking blood sugar levels. The American Diabetes Association (ADA) has recommended screening guidelines. The ADA recommends that the following people be screened for diabetes
  • 58. ANYONE WITH A BODY MASS INDEX HIGHER THAN 25, REGARDLESS OF AGE, • who has additional risk factors, such as high blood pressure, a sedentary lifestyle, a history of polycystic ovary syndrome, having delivered a baby who weighed more than 9 pounds, a history of diabetes in pregnancy, high cholesterol levels, a history of heart disease, and having a close relative with diabetes.
  • 59. ANYONE OLDER THAN AGE 45 • is advised to receive an initial blood sugar screening, and then, if the results are normal, to be screened every three years thereafter.
  • 60. TESTS FOR TYPE 1 AND TYPE 2 DIABETES AND PREDIABETES • Glycated hemoglobin (A1C) test: • This blood test indicates your average blood sugar level for the past two to three months. It measures the percentage of blood sugar attached to hemoglobin, the oxygen-carrying protein in red blood cells. The higher your blood sugar levels, the more hemoglobin you'll have with sugar attached. An A1C level of 6.5 percent or higher on two separate tests indicates that you have diabetes. An A1C between 5.7 and 6.4 percent indicates prediabetes. Below 5.7 is considered normal. • If the A1C test results aren't consistent, the test isn't available, or if you have certain conditions that can make the A1C test inaccurate — so— your doctor may use the following tests to diagnose diabetes:
  • 61.
  • 62. TESTS FOR TYPE 1 AND TYPE 2 DIABETES AND PREDIABETES • Random blood sugar • : A blood sample will be taken at a random time. Regardless of when you last ate, a random blood sugar level of 200 milligrams per deciliter (mg/dL) — 11.1 millimoles per liter (mmol/L) — or higher suggests diabetes.
  • 63. TESTS FOR TYPE 1 AND TYPE 2 DIABETES AND PREDIABETES • Fasting blood sugar test: • A blood sample will be taken after an overnight fast. A fasting blood sugar level less than 100 mg/dL (5.6 mmol/L) is normal. A fasting blood sugar level from 100 to 125 mg/dL (5.6 to 6.9 mmol/L) is considered prediabetes. If it's 126 mg/dL (7 mmol/L) or higher on two separate tests, you have diabetes.
  • 64. TESTS FOR TYPE 1 AND TYPE 2 DIABETES AND PREDIABETES • Oral glucose tolerance test: • For this test, you fast overnight, and the fasting blood sugar level is measured. Then you drink a sugary liquid, and blood sugar levels are tested periodically for the next two hours. A blood sugar level less than 140 mg/dL (7.8 mmol/L) is normal. A reading of more than 200 mg/dL (11.1 mmol/L) after two hours indicates diabetes. A reading between 140 and 199 mg/dL (7.8 mmol/L and 11.0 mmol/L) indicates prediabetes. If type 1 diabetes is suspected, your urine will be tested to look for the presence of a byproduct produced when muscle and fat tissue are used for energy when the body doesn't have enough insulin to use the available glucose (ketones).
  • 66. COMPLICATIONS: • Possible complications include: • Cardiovascular disease. • Diabetes dramatically increases the risk of various cardiovascular problems, including coronary artery disease with chest pain (angina), heart attack, stroke and narrowing of arteries (atherosclerosis). If you have diabetes, you are more likely to have heart disease or stroke.
  • 67. COMPLICATIONS: Nerve damage (neuropathy). Excess sugar can injure the walls of the tiny blood vessels (capillaries) that nourish your nerves, especially in your legs. This can cause tingling, numbness, burning or pain that usually begins at the tips of the toes or fingers and gradually spreads upward. Left untreated, you could lose all sense of feeling in the affected limbs. Damage to the nerves related to digestion can cause problems with nausea, vomiting, diarrhea or constipation. For men, it may lead to erectile dysfunction.
  • 68. COMPLICATIONS:  Kidney damage (nephropathy). The kidneys contain millions of tiny blood vessel clusters (glomeruli) that filter waste from your blood. Diabetes can damage this delicate filtering system. Severe damage can lead to kidney failure or irreversible end-stage kidney disease, which may require dialysis or a kidney transplant.  Eye damage (retinopathy). Diabetes can damage the blood vessels of the retina (diabetic retinopathy), potentially leading to blindness. Diabetes also increases the risk of other serious vision conditions, such as cataracts and glaucoma.
  • 69. COMPLICATIONS:  Foot damage. Nerve damage in the feet or poor blood flow to the feet increases the risk of various foot complications. Left untreated, cuts and blisters can develop serious infections, which often heal poorly. These infections may ultimately require toe, foot or leg amputation.  Skin conditions. Diabetes may leave you more susceptible to skin problems, including bacterial and fungal infections.
  • 70.
  • 71. How Does Insulin Work? 1.In a healthy person, insulin helps turn food into energy -- in an efficient manner. 2. The stomach breaks down carbohydrates from food into sugars, including glucose. Glucose then enters the bloodstream, which stimulates the pancreas to release insulin in just the right amount. 3. Insulin, a hormone, allows glucose to enter cells throughout the body, where it is used as fuel. Excess glucose is stored in the liver.
  • 72.
  • 73. 1.Successful treatment makes all the difference to long-term health, and achieving balanced diabetes treatment can be the key to living with both type 1 and type 2 diabetes. 2.Treatment varies for each individual, not simply on the type of diabetes that they have, but also more individual-specific diabetic treatment differences.
  • 74.
  • 75. INSULIN 1.Inside the pancreas, beta cells make the hormone insulin. With each meal, beta cells release insulin to help the body use or store the glucose it gets from food. 2.Insulin is prescribed to people with type 1 diabetes. This is because type 1 diabetes destroys beta cells in the pancreas, meaning that the body can no longer produce insulin. 2.People with type 2 diabetes make insulin, but their bodies don’t respond well to it. Some people with type 2 diabetes may take pills or insulin shots to help their bodies use glucose for energy.
  • 76.
  • 78. Diabetes Medication -Most diabetes drugs are designed for people with type 2 diabetes who are unable to control their blood sugar levels through strict diet and exercise alone. - But some, such as metformin, are sometimes taken alongside insulin treatment for people with type 1 diabetes.
  • 79. Alpha-glucosidase inhibitors -Alpha-glucosidase inhibitors are oral anti- diabetic drugs used for diabetes mellitus type 2 that work by preventing the digestion of carbohydrates (such as starch and table sugar). - Carbohydrates are normally converted into simple sugars (monosaccharides), which can be absorbed through the intestine. - Hence, alpha-glucosidase inhibitors reduce the impact of carbohydrates on blood sugar.
  • 80. Mechanism of action -Alpha-glucosidase inhibitors are saccharides that act as competitive inhibitors of enzymes needed to digest carbohydrates, specifically alpha- glucosidase enzymes in the brush border of the small intestines. -The membrane-bound intestinal alpha- glucosidases hydrolyze oligosaccharides, trisa ccharides, and disaccharides to glucose and other monosaccharides in the small intestine.
  • 81.
  • 82. Examples of alpha glucosidase inhibitors - Acarbose (Precose): Initial dose: 25 mg orally 3 times a day. Maintenance dose: 50 to 100 mg orally 3 times a day. - Miglitol (Glyset): Initial dose: 25 mg orally 3 times a day at the beginning (with the first bite) of each meal. -Voglibose: The recommended dose is 200-300 mcg 3 times/day.
  • 83. Amylin analogs - Amylin is a 37-amino acid peptide that is stored in pancreatic beta cells and is co- secreted with insulin. -Amylin and insulin levels rise and fall in a synchronous manner . Amylin and insulin have complementary actions in regulating nutrient levels in the circulation. - Amylin is deficient in type 1 diabetes and relatively deficient in insulin-requiring type 2 diabetes
  • 84. -Amylin affects glucose control through several mechanisms, including slowed gastric emptying, regulation of postprandial glucagon, and reduction of food intake. - Glucagon-like peptide 1 (GLP-1) exhibits similar properties as amylin, with the exception of insulin secretory effects. Amylin, unlike GLP-1, does not have insulin secretory effects, but both regulate hyperglycemia in part through amelioration of inappropriate glucagon secretion and gastric emptying
  • 85.
  • 86. There is only one known example of amylin analog that is pramlintide acetate that is an injectable effective in both type 1 and type 2 diabetes.
  • 87. Biguanidine drugs Mechanistic aspects: -Biguanides do not affect the output of insulin, unlike other hypoglycemic agents such as sulfonylureas and meglitinides. -Therefore, not only are they effective in Type 2 diabetics but they can also be effective in Type 1 patients in concert with insulin therapy. - The mechanism of action of biguanides is not fully understood. Mainly used in Type II Diabetes, Metformin is considered to increase insulin sensitivity in vivo, resulting in reduced plasma glucose concentrations, increased glucose uptake, and decreased gluconeogenesis.
  • 88.
  • 89. Examples Of biguanides: Metformin: -widely used in treatment of diabetes mellitus type 2 - 500 mg orally twice a day (with the morning and evening meal) Phenformin: - withdrawn from the market in most countries due to toxic effects. Buformin: - withdrawn from the market due to toxic effects
  • 90. SULFONYLUREAS - Sulfonylurea (UK: sulphonylurea) derivatives are a class of antidiabetic drugs. -They are used in the management of diabetes mellitus type 2. They act by increasing insulin release from the beta cells in the pancreas. - There are two generations of sulfonylureas, both being oral hypoglycemic agents used in type diabetes mellitus.
  • 91. Mechanism of action: -Sulfonylureas bind to an ATP-dependent K+(KATP) channel on the cell membrane of pancreatic beta cells. -This inhibits a tonic, hyperpolarizing efflux of potassium, thus causing the electric potential over the membrane to become more positive. -This depolarizationopens voltage-gated Ca2+ channels. The rise in intracellular calcium leads to increased fusion of insulin granulae with the cell membrane, and therefore increased secretion of (pro)insulin.
  • 92.
  • 93. Drugs in this class First generation: - Carbutamide - Acetohexamide -Chlorpropamide - Tolbutamide Second generation: - Gliclazide - Glibenclamide (glyburide) - Glibornuride - Glimepiride
  • 94. THIAZOLIDINEDIONE - Thiazolidinediones , also known as glitazones, are a class of medications used in the treatment of diabetes mellitus type 2 Mechanism of action: - Thiazolidinediones or TZDs act by activating PPARs (peroxisome proliferator- activated receptors), a group of nuclear receptors, with greatest specificity for PPARγ (gamma). The endogenous ligands for these receptors are free fatty acids (FFAs) and eicosanoids
  • 95. - When activated, the receptor binds to DNA in complex with the retinoid X receptor (RXR), another nuclear receptor, increasing transcription of a number of specific genes and decreasing transcription of others. - Although there are still many unknowns about the mechanism of action of TZDs in type 2 diabetes, it is clear that these agents have the potential to benefit the full 'insulin resistance syndrome' associated with the disease. Therefore, TZDs may also have potential benefits on the secondary complications of type 2 diabetes, such as cardiovascular disease.
  • 96.
  • 97. Members of the class Rosiglitazone (Avandia) Pioglitazone (Actos) Troglitazone (Rezulin) Initial dose: 4 mg/day orally as a single daily dose or in two divided doses. Doses may be taken without regard to meals. Maintenance dose: The dose may be increased to 8 mg daily in patients who fail to respond adequately following 12 weeks of initial therapy. Initial dose: 15 mg to 30 mg orally once a day. Doses may be taken without regard to meals. Maintenance dose: In patients who respond inadequately to the initial dose, it may be increased in increments up to 45 mg once daily.
  • 103. Q. CAN YOU ‘CATCH’ DIABETES? No,
  • 104. Q. AT WHAT AGE DO YOU GET DIABETES? A. Anyone can get diabetes at any age.
  • 105. Q. WHAT TYPES OF PEOPLE GET DIABETES? A. Anyone may develop diabetes.
  • 106. Q. HOW CAN I TELL IF I HAVE DIABETES? A. By the symptoms.
  • 107. Q. CAN DIABETES BE CURED? A. As yet there is no cure. However, excellent treatment is available.
  • 109. DIABETES AND DIET CHOOSE HIGH-FIBER, SLOW- RELEASE CARBOHYDRATES Instead of… Try these high-fiber options… White rice Brown rice or wild rice White potatoes (including fries and mashed potatoes) Sweet potatoes, yams, winter squash, cauliflower mash Regular pasta Whole-wheat pasta White bread Whole-wheat or whole-grain bread Corn Peas or leafy greens
  • 110. DIABETES AND DIET (CONT). Be smart about sweets
  • 111. DIABETES AND DIET (CONT.). Proceed with caution when it comes to alcohol
  • 112. DIABETES AND DIET (CONT.). CHOOSE FATS WISELY • Ways to reduce unhealthy fats and add healthy fats: Instead of… Try these options… vegetable oil or butter Cook with olive oil chips or crackers, try snacking on nuts or seeds. frying grill, broil, bake, or stir-fry. Red meat. Serve fish 2 or 3 times week cheese Add avocado to your sandwiches shortening or butter When baking, use canola oil
  • 113. NUTRITIVE CHART •Fruits:- • 1 serving contain:- protein 1 gm carbohydrate 15 gm Sodium 5 mg Potassium 150 mg Kcal 60
  • 114. FRUIT ITEMS Serving size:- Grape fruit ½ medium Grapes 22 Mango ½ medium peach 1 small pineapple ½ medium Apple 1 medium
  • 115. VEGETABLES • 1 Serving contains:- Protein 2 gm Carbohydrate 5 gm Sodium 10 mg Potassium 200 mg Kcal 25
  • 116. VEGETABLES Food items Serving size. Cabbage ½ Cup Carrot ½ Cup Cauliflower ½ Cup Cucumber 1 Cup Onions ½ Cup Peas 1/4 Cup Potatoes ½ Cup
  • 117. MEAT 1 serving contain:- protein 8 gm Fat 3 gm Sodium 25 mg potassium 100 mg Kcal 55-75
  • 118. MEAT Food items Serving Size Beef 1 Oz Chicken 1 Oz Fish 1 Oz Large Egg 1
  • 119. FOODS TO AVOID • BANANA • DATES • WATER MELON • ORANGE • POMGRANATE • PAPAYA • Red meat
  • 120. COUNSELING REGARDING LIFESTYLE MODIFICATION (NON-PHARMACOLOGICAL THERAPY) • Diabetes and Exercise: Type II (desired level is 3-4 times a week) Type I (Care must be taken to have adequate metabolic control) Exercise is not recommended if patient has poorly controlled blood glucose level